China-based medical imaging technology provider Keya Medical has received RMB150m ($21.6m) in a series B-plus round featuring an investment vehicle backed by internet company Kunlun Tech, DealStreetAsia reported yesterday.
Kunlun Internet Intelligent Industrial Investment Fund, which was co-founded by Kunlun, joined venture capital firm GGV Capital, which led the round, investment holding group Shanghai International Group’s Shanghai Guofang FOF fund and VC fund Alwin Capital.
Keya has created an artificial intelligence-equipped system to detect cardiovascular disease. It is also working on a device that will detect coronavirus through CT scans of a patient’s lungs.
Kunlun and VC group IDG Capital led a $14.3m series B round for the company in February this year that also featured Shanghai Guofang FOF and Yahui Capital. The latest funding will support product development and the commercialisation of its technology.
